University of Maryland, Baltimore: clinical-trial pipeline
University of Maryland, Baltimore is the sponsor of 696 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 166 are not yet finished and 5 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 396 |
| Phase 2 | 98 |
| Phase 4 | 81 |
| Phase 1 | 47 |
| Early phase 1 | 29 |
| Phase 1/2 | 23 |
| Phase 3 | 14 |
| Phase 2/3 | 8 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 379 |
| Recruiting | 102 |
| Terminated | 83 |
| Withdrawn or not authorised | 62 |
| Active, not recruiting | 37 |
| Not yet recruiting | 27 |
| Unknown | 4 |
| Suspended or halted | 2 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 121 |
| Psychiatry and mental health | 97 |
| Infectious disease and vaccines | 93 |
| Metabolic and endocrine (diabetes, obesity) | 71 |
| Cardiovascular | 70 |
| Musculoskeletal | 51 |
| Neurology | 46 |
| Gastroenterology and liver | 45 |
| Nephrology and urology | 39 |
| Rare and genetic diseases | 31 |
| Immunology and rheumatology | 29 |
| Respiratory | 20 |
Countries
| Country | Trials |
|---|---|
| United States | 626 |
| Canada | 8 |
| Mali | 7 |
| Malawi | 4 |
| Nigeria | 3 |
| Egypt | 2 |
| Spain | 2 |
| Zambia | 2 |
| Australia | 1 |
| Burkina Faso | 1 |
| Botswana | 1 |
| Guatemala | 1 |
| Hong Kong SAR China | 1 |
| Israel | 1 |
| India | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-21 | New trial posted | A Novel Wire-Reinforced Fenestration of a Hybrid Frozen Elephant Trunk Device for Supra-A… |
| 2026-10-19 | New trial posted | Cardiovascular Impacts of E-cigarettes Among Older Adults |
| 2026-09-29 | New trial posted | Mechanistic Evaluation of Polypharmacy Effects for Pain |
| 2026-09-17 | New trial posted | Targeting HealthY Eating to Maintain Energy While Living With Cancer |
| 2026-09-04 | New trial posted | Ankle Robotics for Error Augmentation After Stroke |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT05459402 | Divided or Single Exposure (DOSE) Study | Phase 2/3 | Recruiting | United States |
| NCT01858896 | GLP-1 and Hypoglycemia | Early phase 1 | Active, not recruiting | United States |
| NCT04486755 | Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048) | Phase 1 | Active, not recruiting | United States |
| NCT04579692 | MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal Neuralgia | Not applicable | Active, not recruiting | United States |
| NCT04699773 | LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138) | Not applicable | Recruiting | United States |
| NCT02995252 | The HOPE Study: Characterizing Patients With Hepatitis B and C | Not applicable | Active, not recruiting | United States |
| NCT06735950 | The Volunteering-in-Place Program for Apathetic Assisted Living Residents With ADRD | Not applicable | Recruiting | United States |
| NCT06367608 | MRgFUS Pallidotomy for the Treatment of Task Specific Focal Hand Dystonia (TSFD) | Not applicable | Recruiting | United States |
| NCT07221812 | Continuous Glucose Monitors (CGMs) and Readmission Rates | Not applicable | Not yet recruiting | United States |
| NCT05160701 | Bringing Health Home | Not applicable | Active, not recruiting | United States |
| NCT06396650 | Assessment of Fall Risks and Subject-specific Training for Fall Reduction | Not applicable | Recruiting | United States |
| NCT07093281 | Intranasal LAIV Mucosal Immunity Examination | Phase 4 | Not yet recruiting | United States |
| NCT04609280 | Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110) | Phase 2 | Active, not recruiting | United States |
| NCT05444335 | Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years | Not applicable | Active, not recruiting | United States |
| NCT07537413 | Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia | Phase 4 | Not yet recruiting | United States |
| NCT06501781 | Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Act… | Not applicable | Recruiting | United States |
| NCT03970304 | CVD 37000: Immunity and Microbiome Studies at Intestinal and Systemic Sites in Ty21a Vaccinated Adults | Phase 4 | Active, not recruiting | United States |
| NCT03446456 | Vasopressin and Pain Perception in the Brain | Phase 1/2 | Recruiting | United States |
| NCT06074198 | Sickle Cell Children's Exercise Study (SuCCESs) | Not applicable | Active, not recruiting | United States |
| NCT04189471 | Improving Outcomes for Patients With Life-Threatening Neurologic Illness | Not applicable | Recruiting | United States |
| NCT02445781 | Differing Levels of Hypoglycemia | Early phase 1 | Recruiting | United States |
| NCT06864936 | Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis | Not applicable | Recruiting | United States |
| NCT06465290 | Promoting Neuroplastic Changes of Patients With TBI | Not applicable | Recruiting | United States |
| NCT07320989 | Impact of Chewing Gum on Bowel Preparation in Patients Undergoing Colonoscopy | Not applicable | Active, not recruiting | United States |
| NCT07075510 | Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders | Phase 1/2 | Recruiting | United States |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "University of Maryland, Baltimore clinical trials: 166 open, 22 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/university-of-maryland-baltimore/, data as of 2026-10-25.